[Exogenous activated protein C in severe sepsis].

Mamontova, O A; Protsenko, D N; Eliutin, D V; Kirienko, P N; Gel'fand, B R

Mamontova, O A; Protsenko, D N; Eliutin, D V; Kirienko, P N; Gel'fand, B R.

Anesteziol Reanimatol ; (3): 42-5, 2005.

Article in Ru | MEDLINE | ID: mdl-16076046

Subject(s)

Protein C/therapeutic use; Recombinant Proteins/therapeutic use; Sepsis/drug therapy; APACHE; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Protein C/administration & dosage; Protein C/adverse effects; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Sepsis/metabolism; Sepsis/mortality; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Protein C / Sepsis Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: Ru Journal: Anesteziol Reanimatol Year: 2005 Document type: Article Country of publication: RUSSIA

Search on Google

Add to My VHL

XML

PubMed Links